Article
Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma.
Cancer research and treatment - 1 Jul 2020
Xue Miao, Wu Yanqin, Fan Wenzhe, Guo Jian, Wei Jialiang, Wang Hongyu, Tan Jizhou, Wang Yu, Yao Wang, Zhao Yue, Li Jiaping
Abstract excerpt
PURPOSE: This study aimed to investigate the clinicopathologic features and mutational landscape of patients with hepatitis B virus (HBV)-related advanced hepatocellular carcinomas (HCC) undergoing transcatheter arterial chemoembolization (TACE). MATERIALS AND METHODS: From January 2017 to December 2018, 38 patients newly diagnosed with HBV-related advanced HCC were enrolled in the final analysis. Their...
Topics
Join the communities discussing this publication.
